Comparison of Different First-Line Systemic Therapies in Advanced Biliary Tract Cancer Based on Updated Random Controlled Trials: A Systematic Review and Network Meta-Analysis

<div>Network plot and funnel plot of studies included GemCis, gemcitabine plus cisplatin; GemOxa, gemcitabine plus oxaliplatin; GemS1, gemcitabine plus S-1; S1Cis, S1 plus cisplatin; XELOX, capecitabine plus oxaliplatin; BSC, best supportive care; FUFA, fluorouracil+folinic; and FOLFIRINOX, oxaliplatin plus irinotecan plus infusional fluorouracil.</div>

BioMed Research International

fig3

Figure 3

Figure 3: Comparison of Different First-Line Systemic Therapies in Advanced Biliary Tract Cancer Based on Updated Random Controlled Trials: A Systematic Review and Network Meta-Analysis 

Figure 3 | Comparison of Different First-Line Systemic Therapies in Advanced Biliary Tract Cancer Based on Updated Random Controlled Trials: A Systematic Review and Network Meta-Analysis 